IL2RA (CD25) is a type I transmembrane glycoprotein consisting of:
Extracellular domain: Binds IL-2 with low affinity (Kd ~10⁻⁸ M) .
Transmembrane region: Anchors the protein to the cell membrane.
Cytoplasmic domain: Lacks intrinsic signaling capacity, requiring association with IL-2Rβ (CD122) and γc (CD132) chains for high-affinity signaling (Kd ~10⁻¹¹ M) .
In cattle, IL2RA forms part of the high-affinity IL-2 receptor complex alongside IL-2Rβ and γc, enabling IL-2-mediated signaling via JAK-STAT, PI3K/AKT/mTOR, and MAPK pathways .
Bovine IL2RA shares structural and functional homology with human and murine counterparts but exhibits unique binding properties:
Data sourced from equilibrium binding studies in bovine lymphocytes and comparative receptor analyses .
Recombinant bovine IL2RA is utilized in veterinary immunology research, particularly for studying:
T-cell activation: IL2RA expression is critical for IL-2-driven proliferation of CD4⁺ and CD8⁺ T cells .
Regulatory T cells (Tregs): Bovine Tregs require IL2RA for maintenance and suppression of autoimmune responses .
Bovine tuberculosis (bTB): IL2RA levels correlate with T-cell activation during Mycobacterium bovis infection .
Cancer immunotherapy: Soluble IL2RA (sIL2RA) levels may reflect tumor burden in cattle .
The Bovine IL2RA ELISA Kit (Assay Genie, BOEB0128) enables precise quantification of IL2RA in serum, plasma, or cell cultures:
| Parameter | Specification |
|---|---|
| Detection Range | 0.156–10 ng/mL |
| Sensitivity | 0.06 ng/mL |
| Specificity | Bovine IL2RA (non-covalent dimer) |
| Applications | Monitoring immune responses, autoimmune diseases |
Data from Assay Genie’s technical specifications .
While human IL2RA is extensively studied, bovine IL2RA research remains limited. Key gaps include:
Mechanistic studies: Direct evidence of bovine IL2RA’s role in Treg-mediated immune suppression.
Therapeutic potential: Development of recombinant IL2RA as a tool for enhancing vaccine efficacy or treating autoimmune disorders in cattle.
Genetic variations: Impact of IL2RA polymorphisms on disease susceptibility in bovines .
Function: The Recombinant Bovine Interleukin-2 receptor subunit alpha (IL2RA) is a receptor for interleukin-2. It plays a crucial role in regulating immune tolerance by controlling the activity of regulatory T cells (TREGs). TREGs suppress the activation and expansion of autoreactive T-cells.
Bovine IL2RA (CD25) is a 55 kDa type I membrane glycoprotein that functions as the low-affinity receptor subunit for IL-2. Structurally, bovine IL2RA shares approximately 60-64% amino acid sequence identity with human IL2RA . The mature bovine IL2RA protein contains an extracellular domain, a transmembrane region, and a short cytoplasmic tail.
When comparing receptor functionality:
Bovine IL2RA alone binds IL-2 with low affinity
In combination with IL-2R beta and common gamma chain (γc), it forms the high-affinity heterotrimeric receptor complex
The trimeric receptor configuration is essential for optimal IL-2 signaling in bovine T cells
Unlike human IL2RA which can exist in multiple isoforms due to alternative splicing, bovine IL2RA appears to have fewer documented splice variants, though this area requires further research .
Expression patterns of bovine IL2RA follow cell type-specific distributions similar to other mammalian species but with some distinct characteristics:
| Cell Type | Bovine IL2RA Expression | Human IL2RA Expression |
|---|---|---|
| CD4+ Regulatory T cells | Constitutively high | Constitutively high |
| Resting CD4+ T cells | Low/negligible | Low/negligible |
| Activated CD4+ T cells | Rapidly induced | Rapidly induced |
| CD8+ T cells | Activation-dependent | Activation-dependent |
| γδ T cells | Present on activated subset | Less prominent |
| Dendritic cells | Low levels | Low levels |
| B cells | Activation-dependent | Activation-dependent |
Notably, bovine γδ T cells represent a larger proportion of the T cell compartment compared to humans and may have distinct IL2RA expression patterns following activation, particularly important in bovine disease models .
Methodologically, flow cytometric analysis of IL2RA expression should be performed using bovine-specific or cross-reactive anti-CD25 antibodies, with appropriate isotype controls to account for the higher background often observed with bovine samples .
Isolation and purification of recombinant bovine IL2RA can be achieved through several complementary approaches:
Expression System Selection:
E. coli expression systems can be used for non-glycosylated portions of the extracellular domain
Insect cell (baculovirus) systems are more suitable for full-length glycosylated protein
Mammalian expression systems (CHO or HEK293 cells) provide the most native post-translational modifications
Purification Strategy:
Affinity chromatography using:
Follow with size exclusion chromatography to remove aggregates and ensure monomeric protein
Confirm purity via SDS-PAGE and Western blot analysis using specific anti-bovine IL2RA antibodies
Quality Control Parameters:
Functional validation through binding assays with recombinant IL-2
Glycosylation analysis if expressed in eukaryotic systems
Researchers should note that carrier-free preparations are recommended for structural studies and binding assays where BSA might interfere .
Phospho-flow cytometry optimization for bovine IL2RA-mediated STAT5 signaling requires attention to several critical parameters:
Stimulation Conditions:
Optimal IL-2 concentration: 10 IU/ml provides robust but non-saturating response for detecting differences in signaling intensity
Stimulation time: 15 minutes at 37°C in water bath yields consistent pSTAT5 detection
Include unstimulated controls and IL-7 stimulation (signals through CD127, not CD25) as specificity control
Cell Fixation and Permeabilization:
Use pre-warmed Cytofix buffer (37°C) for 10 minutes to preserve phospho-epitopes
Wash carefully to reduce background staining
Antibody Selection:
Anti-pSTAT5 (Y694) antibodies that cross-react with bovine epitopes
Include fluorescence minus one (FMO) controls
Consider multiplexing with surface markers (CD4, CD8, WC1 for γδ T cells)
Data Analysis:
Use geometric mean fluorescence intensity rather than percent positive cells
Calculate stimulation index: pSTAT5 MFI stimulated ÷ pSTAT5 MFI unstimulated
Implement statistical methods that account for non-normal distribution of phosphorylation data
This approach allows quantitative assessment of signaling differences between IL2RA-expressing cell populations and can detect altered signaling in disease states or following experimental manipulation .
The differential responsiveness to IL-2 between bovine regulatory T cells (Tregs) and effector T cells (Teff) involves several molecular mechanisms:
Receptor Expression Profile:
Bovine Tregs constitutively express high levels of IL2RA (CD25), while Teff cells express lower baseline levels
This differential expression creates a hierarchy of IL-2 sensitivity similar to humans
Signaling Pathway Differences:
STAT5 Phosphorylation Dynamics:
Regulatory Components:
Differential expression of negative regulators (SOCS proteins)
Varied expression of phosphatases that terminate signaling
Functional Consequences:
In physiological conditions, Tregs preferentially capture and respond to limited IL-2
Under inflammatory conditions, increased IL-2 production allows activation of both Tregs and Teff cells
This balance is critical for maintaining immune homeostasis in cattle
Methodologically, researchers can investigate these differences through:
Comparative phosphoproteomic analysis of purified bovine Tregs vs. Teff cells
Transcriptional profiling of IL-2 responsive genes
IL-2 partial agonists demonstrate differential effects based on IL2RA expression levels, providing important research tools for understanding receptor function:
Mechanistic Basis:
Partial agonists with mutations in γc binding interface modulate receptor dimerization efficiency
This creates submaximal signaling even at saturating cytokine concentrations
The degree of partial agonism correlates with the efficiency of receptor heterodimer formation
Cell-type Specific Effects:
| Cell Type | IL2RA Expression | Response to IL-2 Partial Agonists |
|---|---|---|
| Tregs | High | More sensitive to partial agonists |
| Memory CD4+ T cells | Intermediate | Moderate activation |
| Naive T cells | Low | Minimal response |
| NK cells | Low (IL2RB/γc only) | Diminished response |
Experimental Applications:
Selective Treg expansion using IL-2 partial agonists with preserved IL2RA binding but reduced IL2RB/γc recruitment
Dissection of signaling thresholds across bovine T cell subpopulations
Therapeutic potential in bovine autoimmune or inflammatory conditions
The research methodology involves:
Engineering specific mutations in IL-2 (e.g., at positions that contact γc)
Dose-response experiments across different bovine cell populations
Analysis of downstream signaling events (pSTAT5, pAKT, pERK)
Distinguishing between soluble and membrane-bound bovine IL2RA presents several technical challenges that require specific methodological approaches:
Sample Processing Considerations:
Collection timing: Soluble IL2RA levels can increase during improper sample handling due to proteolytic release
Anticoagulant selection: EDTA or citrate preferred over heparin which may interfere with some assays
Centrifugation protocols: Standardize speed and temperature to minimize artifactual release
Assay Design Challenges:
Antibody specificity: Ensure antibodies detect the same epitope regions on both soluble and membrane-bound forms
Epitope masking: Soluble IL2RA may have different accessible epitopes than membrane-bound forms
Cross-reactivity: Commercial antibodies may have variable specificity for bovine IL2RA
Quantitative Methods:
Flow cytometry for membrane-bound IL2RA:
Directly conjugated antibodies minimize background
Calibration beads allow conversion to absolute molecules per cell
ELISA for soluble IL2RA:
Immunoprecipitation followed by Western blot:
Allows size discrimination between full-length and truncated forms
Limited by antibody sensitivity and specificity
Validation Approaches:
Spike-and-recovery experiments with recombinant bovine IL2RA
Parallel measurement of known soluble IL2RA-inducing stimuli
Comparison between fresh and freeze-thawed samples to assess artifactual release
T cell receptor (TCR) sequencing provides insights into the relationship between clonal expansion and IL2RA expression in bovine immune responses:
Methodological Approach:
Cell Isolation and Sorting:
TCR Library Construction:
Data Analysis Framework:
Diversity metrics: Assess clonality, richness, and evenness in IL2RA-high vs. IL2RA-low populations
Tracking specific clones: Monitor expansion of identified TCR sequences upon antigen exposure
Correlation analysis: Relate IL2RA expression levels to TCR diversity parameters
Research Findings:
Increased clonality in IL2RA-high populations suggests antigen-driven expansion
Public clonotypes with shared TCR sequences more frequently found in activated IL2RA-positive cells
Convergent evolution of TCR sequences in response to common bovine pathogens correlates with IL2RA upregulation
This combined approach allows researchers to link functional phenotypes (IL2RA expression) with the molecular identity of specific T cell clones, providing insights into bovine adaptive immune responses .
Engineered IL-2 mutants with reduced IL2RA binding demonstrate cell type-specific effects on bovine immune function:
Design Approaches for IL-2 Mutants:
Point mutations at key IL2RA interaction sites:
Computational design of de novo IL-2 mimetics:
Functional Impact on Bovine Immune Cells:
| Cell Type | Normal Response to Wild-type IL-2 | Response to IL2RA-deficient Mutants |
|---|---|---|
| CD4+CD25high Tregs | Strong proliferation and STAT5 activation | Significantly reduced response |
| Conventional CD4+ T cells | Moderate response dependent on activation state | Reduced but still detectable |
| CD8+ T cells | Strong response when activated | Maintained response |
| NK cells | Moderate response | Maintained or enhanced response |
| Memory T cells | Activation-dependent | Enhanced relative to Tregs |
Experimental Observations:
Reduced PBMC proliferation and IFN-γ secretion with IL2RA-deficient mutants compared to wild-type IL-2
Preferential activation of memory T cells and NK cells over Tregs
Altered kinetics of STAT5 phosphorylation with more transient signaling
These engineered cytokines serve as valuable research tools for selective activation of specific bovine immune cell subsets and potential therapeutic applications in cattle diseases .
Surface plasmon resonance (SPR) provides detailed insights into the binding kinetics between bovine IL2RA and IL-2 when properly optimized:
Experimental Setup:
Protein Preparation:
Surface Chemistry:
Biotinylated IL2RA can be immobilized on streptavidin sensor chips at low density (<100 RU)
His-tagged IL2RA can be captured on Ni-NTA sensor chips
Alternative: immobilize IL-2 and flow IL2RA as analyte
Measurement Parameters:
Temperature: Standardize at 25°C for consistency
Flow rate: 50 μL/min provides good mass transport without excessive sample consumption
Association phase: 120 seconds
Dissociation phase: 500 seconds to capture slow dissociation kinetics
Regeneration: 4M MgCl₂ effectively regenerates the surface without damaging immobilized proteins
Data Analysis Approach:
Reference subtraction: Use unrelated protein immobilized in reference channel
Blank injections: Buffer-only runs to account for bulk refractive index changes
Fitting models:
1:1 Langmuir binding for simple interactions
Heterogeneous ligand model if multiple binding sites are present
Consider mass transport limitations in analysis
Expected Parameters:
Based on human and bovine studies, expected binding parameters include:
For IL2RA alone: KD approximately 6-10 nM, representing low-affinity binding
For high-affinity trimeric receptor complex: KD in picomolar range (10-20 pM)
Association rate (ka): 10⁵-10⁶ M⁻¹s⁻¹
This detailed kinetic analysis provides quantitative comparison of wild-type and mutant IL-2 interactions with bovine IL2RA .